BOSTON (AP) — A new federal report has concluded that the authority to regulate pharmacies engaged in drug compounding is ‘‘unclear’’ and ‘‘inconsistent’’ at the state and federal levels.
The Government Accountability Office also found that federal circuit court decisions have given the Food and Drug Administration different oversight authority in different parts of the country.
continue to read here
No comments:
Post a Comment